BANGKOK – A Big Pharma star player – Sanofi Aventis – has been battling a stock market tsunami these past few days. It was all caused by a negative rumor about one of its best-selling products, Lantus (or glargine) – an insulin-a-day wonder that is key in the fight against diabetes. Tens of thousands of […]